Literature DB >> 19559497

LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases).

Katsuyuki Takeuchi1, Sho Ogata, Kuniaki Nakanishi, Yuichi Ozeki, Sadayuki Hiroi, Susumu Tominaga, Shinsuke Aida, Hirotaka Matsuo, Tsuneaki Sakata, Toshiaki Kawai.   

Abstract

OBJECTIVE: System l-amino acid transport mediates the uptake of aromatic neutral amino acids and nutritionally essential amino acids from extracellular fluids. Little is known about the role of l-amino acid transporter 1 (LAT1), a member of the system l-amino acid transporter family, in non-small-cell lung carcinomas (NSCLCs). PATIENTS AND METHODS: We examined (i) LAT1 mRNA levels in 40 normal lung tissues (NLTs) and 237 NSCLCs using semiquantitative RT-PCR, (ii) LAT1 protein expression in 295 NSCLCs using immunohistochemistry, and (iii) whether LAT1 mRNA and protein expressions were related to clinicopathologic findings and outcome.
RESULTS: The LAT1 mRNA level was significantly higher in all NSCLCs (6.81+/-1.13) than in NLT (1.00+/-0.18). The LAT1 mRNA level showed no association with clinicopathologic findings or outcome. LAT1 protein was detected with a diffuse or granular appearance within the cytoplasm and/or on the plasma membrane of tumor cells. When tumors were graded as positive if staining indicating a plasma membrane expression of LAT1 protein made up more than 10% of the tumor, the frequency of this membrane expression was found to be associated with tumor histology, differentiation grade, pathologic stage, T classification, pleural invasion, lymph-vessel invasion, and overall survival rate.
CONCLUSION: Detection of a plasma membrane expression of LAT1 protein would appear to be of value in informing the prognosis in NSCLC cases. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559497     DOI: 10.1016/j.lungcan.2009.05.020

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  19 in total

1.  LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs.

Authors:  Evan Augustyn; Karissa Finke; Arik A Zur; Logan Hansen; Nathan Heeren; Huan-Chieh Chien; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-04-11       Impact factor: 2.823

2.  GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.

Authors:  Keshuo Ding; Sheng Tan; Xing Huang; Xiaonan Wang; Xiaocan Li; Rong Fan; Yong Zhu; Peter E Lobie; Wenbin Wang; Zhengsheng Wu
Journal:  J Biol Chem       Date:  2018-01-24       Impact factor: 5.157

3.  l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.

Authors:  Colton Hall; Hannah Wolfe; Alyssa Wells; Huan-Chieh Chien; Claire Colas; Avner Schlessinger; Kathleen M Giacomini; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2019-06-20       Impact factor: 2.823

4.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

5.  Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.

Authors:  Rianot Amzat; Pooneh Taleghani; Daniel L Miller; Jonathan J Beitler; Leah M Bellamy; Jonathon A Nye; Weiping Yu; Bital Savir-Baruch; Adeboye O Osunkoya; Zhengjia Chen; William F Auffermann; Mark M Goodman; David M Schuster
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

6.  Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).

Authors:  Huan-Chieh Chien; Claire Colas; Karissa Finke; Seth Springer; Laura Stoner; Arik A Zur; Brooklynn Venteicher; Jerome Campbell; Colton Hall; Andrew Flint; Evan Augustyn; Christopher Hernandez; Nathan Heeren; Logan Hansen; Abby Anthony; Justine Bauer; Dimitrios Fotiadis; Avner Schlessinger; Kathleen M Giacomini; Allen A Thomas
Journal:  J Med Chem       Date:  2018-08-10       Impact factor: 7.446

7.  L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer.

Authors:  Atsuki Segawa; Shushi Nagamori; Yoshikatsu Kanai; Nobuhide Masawa; Tetsunari Oyama
Journal:  Mol Clin Oncol       Date:  2012-12-20

Review 8.  Imaging tumor metabolism using positron emission tomography.

Authors:  David Y Lewis; Dmitry Soloviev; Kevin M Brindle
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

9.  The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake.

Authors:  Brooklynn Venteicher; Kasey Merklin; Huy X Ngo; Huan-Chieh Chien; Keino Hutchinson; Jerome Campbell; Hannah Way; Joseph Griffith; Cesar Alvarado; Surabhi Chandra; Evan Hill; Avner Schlessinger; Allen A Thomas
Journal:  ChemMedChem       Date:  2020-12-11       Impact factor: 3.466

10.  Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas.

Authors:  Zhen Haining; Nobuyuki Kawai; Keisuke Miyake; Masaki Okada; Shuichi Okubo; Xiang Zhang; Zhou Fei; Takashi Tamiya
Journal:  BMC Clin Pathol       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.